Stay updated on 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial
Sign up to get notified when there's something new on the 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial page.

Latest updates to the 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record now presents details of the liraglutide trial for weight regain after gastric bypass, including its eligibility criteria, study design, interventions, outcomes, and results history. It also includes a study protocol and statistical analysis plan.SummaryDifference46%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in agency content.SummaryDifference1%

- Check30 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error, preventing access to the study record content; the visible change includes a 403 header and standard site footer while the main study details are effectively removed from view.SummaryDifference18%

Stay in the know with updates to 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial page.